Several studies have reported a link between tau pathology and impaired insulin signaling in the AD brain (Gonçalves et al., 2019; El Idrissi and Alonso, 2022; Ennis et al., 2023); however, the underlying mechanism remains unknown. Here, MAPT is linked to Alzheimer disease.